Travel nurses and other allied health professionals now have a new method to take charge of their professional futures thanks to MedPro Experience+ (MPX+), a new initiative from MedPro Healthcare Staffing, a market leader in contract healthcare staffing services. The power is in the travellers’ hands with MPX+. Users can […]
Featured News
Xtalpi And CK Life Sciences To Collaborate In AI-empowered Tumour Vaccine Research And Development, Opening A New Paradigm For Scientific Innovation
Yesterday, XtalPi made a strategic partnership announcement with CK Life Sciences, a part of the CK Hutchison Group. To enhance the discovery and design capabilities of tumour vaccines and speed up the creation of more vaccine kinds, XtalPi and CK Life Sciences will combine their respective skills to establish a […]
Feinstein Institutes Awarded $3.6M From New York State For Spinal Cord Injury Research
Feinstein Institutes Awarded $3.6M From New York State For Spinal Cord Injury Research In order to govern our motions and process sensations, the spinal cord functions as the information highway, conveying impulses to and from our brain. A spinal cord injury (SCI) can cause paralysis, sometimes affecting all four limbs. […]
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B
Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy, has been approved by the U.S. Food and Drug Administration for the treatment of adults with Haemophilia B (congenital factor IX deficiency) who are currently receiving Factor IX prophylaxis therapy, have experienced recent or past life-threatening hemorrhage, or have had recurrent, […]
Blue Cross Blue Shield Of Massachusetts Supports Vaccination To Help Prevent The Spread Of Flu
With the holiday season approaching and the AAA forecasting more holiday travel, Blue Cross and Blue Shield of Massachusetts, Inc. (Blue Cross) are encouraging everyone to get the flu vaccine and COVID-19 booster shot. I am urging you. “The best way to protect yourself and your loved ones is to […]
Jazz Pharmaceuticals Announces U.S. FDA Approval of Monday/Wednesday/Friday Intramuscular Dosing Schedule for Rylaze®
Jazz Pharmaceuticals Announces U.S. FDA Approval For Intramuscular Dosing Schedule for Rylaze Rylaze dosing option provides sustained asparaginase activity throughout the course of treatment for adult and pediatric patients with acute lymphoblastic leukemia or lymphoblastic lymphoma Jazz Pharmaceuticals plc announced today that in the United States the Food and Drug […]
Medidata Launches Rave Companion, the First Scalable Solution to Automate EHR Data Entry in Rave EDC
For clinical trial sites and data administrators, Rave Companion modernises the CDE user experience and prevents thousands of avoidable errors. Because Rave Companion enters EHR source data into Rave EDC with less typing and fewer errors, it improves data quality and can save monitoring expenses. The solution brings a patient’s […]
Google Cloud Launches New ‘Accelerators’ to Help Healthcare Companies Improve Health Equity, Patient Flow, and Value-Based Care
Collaboration with organisations like Lifepoint Health, Hackensack Meridian Health, and others will help businesses operate more successfully and provide better patient care. Today at HLTH 2022, Google Cloud unveiled three new Healthcare Data Engine (HDE) accelerators that support organisations in addressing common use cases related to health equity, patient flow, […]
Indivior To Acquire Opiant Pharmaceuticals
According to a definitive agreement between Indivior PLC and Opiant Pharmaceuticals, Inc., which the two companies announced today, Indivior will buy Opiant for an upfront payment of $20.00 per share in cash (roughly $145 million total), plus up to $8.00 per share in contingent value rights (“CVRs”) that could become […]
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
Creating a New Paradigm in Precision Medicine for The Company Fulgent Pharma Holdings, Inc., an independent clinical-stage, therapeutics development company focused on the development of cutting-edge cancer treatments, has been acquired by Fulgent Genetics, Inc., a technology-based genetic testing business focused on transforming patient care in oncology, infectious and rare […]
